A majority of investors in the Nexus funds of Camden Partners supported the spinout this month of its Nexus Management group into a new firm, Catalio Capital, according to people familiar with the situation. Baltimore-based Catalio invests in biomedical startups and growth-stage companies. Catalio’s spinout came amid fundraising for the second...

Source: Wall Street Journal June 29, 2020 11:03 UTC